Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
29.11
-0.63 (-2.10%)
At close: Feb 4, 2026, 4:00 PM EST
29.03
-0.09 (-0.31%)
Pre-market: Feb 5, 2026, 8:28 AM EST

TG Therapeutics Revenue

TG Therapeutics had revenue of $161.71M in the quarter ending September 30, 2025, with 92.79% growth. This brings the company's revenue in the last twelve months to $531.90M, up 100.88% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.

Revenue (ttm)
$531.90M
Revenue Growth
+100.88%
P/S Ratio
7.99
Revenue / Employee
$1,422,187
Employees
374
Market Cap
4.26B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019152.00K--
Dec 31, 2018152.00K--
Dec 31, 2017152.00K--
Dec 31, 2016152.00K-381.00-0.25%
Dec 31, 2015152.38K--
Dec 31, 2014152.38K--
Dec 31, 2013152.38K133.33K699.98%
Dec 31, 201219.05K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ACADIA Pharmaceuticals1.05B
Corcept Therapeutics741.17M
Amicus Therapeutics598.70M
ADMA Biologics488.56M
Ligand Pharmaceuticals251.23M
Liquidia69.22M
Arcellx35.90M
CG Oncology2.17M
Revenue Rankings

TGTX News

More News